Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?

Creator
Fischer, Melissa A
Keough, Mary Ellen
Baril, Joann L
Saccoccio, Laura
Mazor, Kathleen M
Ladd, Elissa
Von Worley, Ann
Gurwitz, Jerry H
Bibliographic Citation
Journal of general internal medicine 2009 Jul; 24(7): 795-801
Abstract
Research suggests that pharmaceutical marketing influences prescribing and may cause cognitive dissonance for prescribers. This work has primarily been with physicians and physician-trainees. Questions remain regarding why prescribers continue to meet with pharmaceutical representatives (PRs).
Permanent Link
Find in a Library
Full Text from Publisher
http://hdl.handle.net/10822/1027625
Date
2009-07
Subject
Collections
Metadata
Show full item record
Georgetown University Seal
©2009—2018 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885